Literature DB >> 8607330

Effects of L-arginine on utero-placental circulation in growth-retarded fetuses.

I Neri1, V Mazza, M C Galassi, A Volpe, F Facchinetti.   

Abstract

BACKGROUND: To evaluate the effects of L-arginine (ARG) infusion, the nitric oxide as substrate, on the utero-placental circulation at third trimester.
METHODS: Three groups of nine pregnant women each were infused i.v. with 30 g ARG, for 30 minutes. One group served as control, and the two remnants were composed by patients with intrauterine growth retardation with (IUGR-B) or without (IUGR-A) increased resistances in the utero-placental circulation. Changes of blood flow velocity waveforms of both uterine arteries and umbilical artery were recorded for 60 minutes. Blood pressure, serum nitrites/nitrates and growth hormone levels were also measured.
RESULTS: No hemodynamic changes in utero-umbilical circulation were observed during infusion in any of the three groups. Considering the uterine arteries separately as placental and non-placental sided we found a significant decrease of non-placental side resistances in IUGR-B women. Indeed, the pulsatility index was lowered by 14%, in respect of baseline value. Serum nitrites/nitrates as well as serum growth hormone levels were significantly increased by ARG, in every woman, irrespective of the presence of fetal growth retardation. Blood pressure remained unaffected during infusion in every woman.
CONCLUSIONS: These findings suggest that L-arginine infusion affects utero-placental circulation in patients with IUGR associated with increased uterine resistances. Such an action is specific and appears possibly to be mediated by a release of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607330     DOI: 10.3109/00016349609047088

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  14 in total

Review 1.  Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion.

Authors:  H J Kliman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 2.  The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials.

Authors:  T Dorniak-Wall; R M Grivell; G A Dekker; W Hague; J M Dodd
Journal:  J Hum Hypertens       Date:  2013-10-31       Impact factor: 3.012

3.  Placental insufficiency and fetal growth restriction.

Authors:  Usha Krishna; Sarita Bhalerao
Journal:  J Obstet Gynaecol India       Date:  2011-11-17

Review 4.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

5.  Effect of l-Arginine on Nitric Oxide Levels in Intrauterine Growth Restriction and its Correlation with Fetal Outcome.

Authors:  Shalini Singh; Archana Singh; Deepika Sharma; Abha Singh; M K Narula; Jayashree Bhattacharjee
Journal:  Indian J Clin Biochem       Date:  2014-07-15

6.  The effect of antenatal L-arginine and antioxidant supplementation on oxidative stress marker levels in newborns.

Authors:  Shweta Dr; Anuradha Khanna
Journal:  J Clin Diagn Res       Date:  2014-10-20

7.  Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.

Authors:  Jose A Santiago-Font; Lorena M Amaral; Jessica Faulkner; Tarek Ibrahim; Venkata Ramana Vaka; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

Review 8.  Maternal amino acid supplementation for intrauterine growth restriction.

Authors:  Laura D Brown; Alice S Green; Sean W Limesand; Paul J Rozance
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

9.  Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial.

Authors:  Felipe Vadillo-Ortega; Otilia Perichart-Perera; Salvador Espino; Marco Antonio Avila-Vergara; Isabel Ibarra; Roberto Ahued; Myrna Godines; Samuel Parry; George Macones; Jerome F Strauss
Journal:  BMJ       Date:  2011-05-19

Review 10.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.